RecallRadar

FDA Drug recall D-502-2013

DOBUTamine in 5% Dextrose Injection, USP, 250 mg Total, 1000 mcg/mL 250 mL bag, Rx only, HOPIRA, INC., LAKE FOREST, IL 60045 NDC 0409-2346-…

On 2013-06-12 the FDA classified a Class II recall of DOBUTamine in 5% Dextrose Injection, USP, 250 mg Total, 1000 mcg/mL 250 mL bag, Rx only, HOPIRA, INC., LAKE FOREST, IL 60045 NDC 0409-2346-… by Hospira, citing lack of Assurance of Sterility: Confirmed report of leaking in the primary container.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-502-2013
ClassificationClass II
Statusterminated
Initiated2013-04-30
Published2013-06-12
Last updated2026-09-13 11:51 UTC
CompanyHospira
DistributionUS

Product

DOBUTamine in 5% Dextrose Injection, USP, 250 mg Total, 1000 mcg/mL 250 mL bag, Rx only, HOPIRA, INC., LAKE FOREST, IL 60045 NDC 0409-2346-32

Reason

Lack of Assurance of Sterility: Confirmed report of leaking in the primary container.

Identifiers

ndc0409-2347-31
ndc0409-2347-32
ndc0409-2346-31
ndc0409-2346-32
ndc0409-3724-11
ndc0409-3724-32
ndc0409-0025-01
ndc0409-0025-10
ndc0409-0151-01
ndc0409-0151-10
ndc0409-1100-01
ndc0409-1100-10
code_infoLot 11-309-KL

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-502-2013%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.